Market research

Radiation Attenuating Surgical Gloves

Explore licenses

360iResearch introduction

Radiation-Attenuating Surgical Gloves: Executive Overview

Radiation-attenuating surgical gloves are personal protective equipment designed to reduce hand exposure during fluoroscopy- and X-ray-guided procedures. Their relevance is tied to the growing use of image-guided interventions, occupational exposure controls, and requirements for sterile surgical protection. They are not a substitute for time, distance, shielding, exposure monitoring, or established radiation-safety protocols, and their protective performance depends on material composition, thickness, fit, dexterity, and correct use.

Inside the research

Coverage at a glance

Selected branches from the published table of contents. Follow a chapter to explore its complete hierarchy.

  1. Chapter 7 Product Type

    • Composite Gloves
    • Disposable Gloves
    • Reusable Gloves
    View chapter
  2. Chapter 8 Material

    • Latex
    • Neoprene
    • Nitrile
    View chapter
  3. Chapter 9 Application

    • Cardiology
    • Interventional Radiology
    • Oncology
    • Orthopedics
    More in this chapter

How Image-Guided Care Is Reshaping Glove Requirements

The operating environment is shifting toward procedures that combine surgical access with real-time imaging, including interventional cardiology, vascular treatment, orthopedics, pain management, and hybrid operating-room workflows. This increases the importance of gloves that balance attenuation with tactile sensitivity, flexibility, tear resistance, sterility, and ergonomic comfort. Procurement is also becoming more attentive to validated protection claims, contamination control, user training, disposal practices, and compatibility with other protective equipment. Because attenuation performance can vary by energy level and testing method, transparent technical documentation is central to informed purchasing.

Artificial Intelligence Strengthens Exposure Management and Product Selection

Artificial intelligence is influencing radiation-intensive care through procedure planning, image optimization, workflow support, and dose-monitoring analytics. By helping clinicians identify efficient imaging sequences and flag unusually high exposure patterns, AI may support the broader radiation-protection principle of keeping exposure as low as reasonably achievable. Its contribution to glove selection is indirect but practical: analytics can identify procedures, teams, and settings where hand-protection controls deserve closer review. Human oversight remains essential because algorithmic recommendations, dose data, and protective-product performance must be validated against clinical conditions and applicable safety standards.

Regional Insights: Regulation, Procedure Mix, and Procurement Priorities

North America combines extensive use of image-guided procedures with mature occupational-safety programs and structured hospital procurement. Europe places strong emphasis on medical-device conformity, worker protection, and harmonized technical documentation, while the European Union operates within a coordinated regulatory environment. Asia-Pacific includes advanced interventional-care systems alongside rapidly expanding hospital capacity, creating varied requirements for training, affordability, and supply reliability. Latin America is shaped by uneven access to specialized imaging and differences in regulatory enforcement, making education and dependable distribution important. The Middle East is developing advanced tertiary-care and medical-tourism capabilities, whereas Africa presents a more heterogeneous landscape in which infrastructure, equipment availability, and basic radiation-safety resources strongly influence adoption priorities.

Group Insights: Economic and Security Blocs With Different Operating Contexts

ASEAN markets reflect diverse health-system maturity, import requirements, and access to interventional services, so regional strategies need local regulatory and distribution adaptation. BRICS members span large and differing healthcare systems, domestic manufacturing capabilities, and public-procurement models; shared attention to supply resilience does not eliminate national differences. The European Union supports coordinated standards and cross-border procurement considerations, while the G7 generally combines advanced clinical infrastructure with established workplace-safety expectations. GCC countries are investing in specialized healthcare capacity and often prioritize internationally recognized quality documentation. NATO members are not a single healthcare market, but their emphasis on operational readiness and standards-based procurement can make durable, validated protective equipment relevant in military and civilian medical settings.

Country Insights: Clinical Capacity and Regulatory Context Across Priority Markets

Australia and Canada emphasize regulated healthcare procurement and occupational radiation protection. The United States has broad use of interventional imaging and detailed workplace-safety guidance. In Europe, France, Germany, Italy, Spain, and the United Kingdom combine substantial procedural capability with formal medical-device and worker-protection requirements, although regulatory pathways and procurement practices differ. Japan and South Korea have advanced imaging infrastructure and strong quality expectations. China and India combine major tertiary-care capacity with substantial regional variation in access, purchasing power, and institutional protocols. Brazil and Mexico are important Latin American healthcare markets with differing public-private mixes and infrastructure distribution. Russia’s healthcare system and procurement environment require country-specific assessment, particularly regarding regulatory documentation, logistics, and availability of specialized products.

Actions for Leaders: Validate Protection, Fit, Compliance, and Workflow Value

Leaders should begin with a documented exposure assessment by procedure type, imaging system, hand position, and staff role rather than treating all interventions alike. They should require independent or standards-based evidence for attenuation claims, clarify the applicable radiation spectrum and test conditions, and confirm that the product is legally marketable in each target jurisdiction. Clinical evaluations should examine dexterity, tactile feedback, fatigue, skin tolerance, donning technique, puncture resistance, and compatibility with sterile workflows. Procurement teams should pair gloves with comprehensive controls such as shielding, dosimetry, staff training, equipment maintenance, and dose optimization. Finally, organizations should monitor user adherence, glove integrity, incident reports, waste implications, and supplier continuity through a recurring quality-review process.

Research Methodology: Evidence-Led Review of Clinical, Regulatory, and Operational Factors

This executive summary uses a structured review framework focused on the role of radiation-attenuating surgical gloves in image-guided healthcare. The assessment considers published radiation-protection guidance, occupational-safety principles, medical-device requirements, clinical workflow characteristics, and publicly documented healthcare-system conditions across the specified regions, groups, and countries. Interpretation emphasizes verifiable qualitative evidence rather than unsupported commercial claims. Comparisons are limited by differences in national regulations, testing protocols, procedure volumes, terminology, and product labeling; therefore, local validation and current regulatory review are required before purchasing or clinical implementation.

Conclusion: Protective Gloves Are One Layer of a Verified Radiation-Safety Program

Radiation-attenuating surgical gloves can contribute to hand protection during selected image-guided procedures, but their value depends on credible attenuation evidence, appropriate fit and usability, and integration with a complete radiation-safety system. Regional and country conditions differ materially in regulation, clinical infrastructure, procurement, and training capacity. Industry leaders should therefore prioritize validated performance, transparent labeling, clinician acceptance, and measurable workflow outcomes over protection claims considered in isolation. Continuous exposure review and alignment with local standards will remain essential as image-guided care and data-enabled clinical technologies evolve.

Research report

Table of contents

  1. 1.Preface
    1. 1.1Objectives of the Study
    2. 1.2Market Definition
    3. 1.3Market Segmentation & Coverage
    4. 1.4Years Considered for the Study
    5. 1.5Currency Considered for the Study
    6. 1.6Language Considered for the Study
    7. 1.7Key Stakeholders
  2. 2.Research Methodology
    1. 2.1Introduction
    2. 2.2Research Design
      1. 2.2.1Primary Research
      2. 2.2.2Secondary Research
    3. 2.3Research Framework
      1. 2.3.1Qualitative Analysis
      2. 2.3.2Quantitative Analysis
    4. 2.4Market Size Estimation
      1. 2.4.1Top-Down Approach
      2. 2.4.2Bottom-Up Approach
    5. 2.5Data Triangulation
    6. 2.6Research Outcomes
    7. 2.7Research Assumptions
    8. 2.8Research Limitations
  3. 3.Executive Summary
    1. 3.1Introduction
    2. 3.2CXO Perspective
    3. 3.3New Revenue Opportunities
    4. 3.4Next-Generation Business Models
    5. 3.5Industry Roadmap
  4. 4.Market Overview
    1. 4.1Introduction
    2. 4.2Industry Ecosystem & Value Chain Analysis
      1. 4.2.1Supply-Side Analysis
      2. 4.2.2Demand-Side Analysis
      3. 4.2.3Stakeholder Analysis
    3. 4.3Market Dynamics
      1. 4.3.1Key Drivers
      2. 4.3.2Key Restraints
      3. 4.3.3Key Opportunities
      4. 4.3.4Key Challenges
    4. 4.4Porter’s Five Forces Analysis
    5. 4.5PESTLE Analysis
    6. 4.6Market Outlook
      1. 4.6.1Near-Term Market Outlook (0–2 Years)
      2. 4.6.2Medium-Term Market Outlook (3–5 Years)
      3. 4.6.3Long-Term Market Outlook (5–10 Years)
    7. 4.7Go-to-Market Strategy
  5. 5.Market Insights
    1. 5.1Consumer Insights & End-User Perspective
    2. 5.2Consumer Experience Benchmarking
    3. 5.3Opportunity Mapping
    4. 5.4Distribution Channel Analysis
    5. 5.5Pricing Trend Analysis
    6. 5.6Regulatory Compliance & Standards Framework
    7. 5.7ESG & Sustainability Analysis
    8. 5.8Disruption & Risk Scenarios
    9. 5.9Return on Investment & Cost-Benefit Analysis
  6. 6.Cumulative Impact of Artificial Intelligence 2026
  7. 7.Radiation Attenuating Surgical Gloves Market, by Product Type
    1. 7.1Introduction
    2. 7.2Composite Gloves
    3. 7.3Disposable Gloves
    4. 7.4Reusable Gloves
      1. 7.4.1Lead Composite Gloves
      2. 7.4.2Lead Rubber Gloves
      3. 7.4.3Leaded Finger Guards
  8. 8.Radiation Attenuating Surgical Gloves Market, by Material
    1. 8.1Introduction
    2. 8.2Latex
    3. 8.3Neoprene
    4. 8.4Nitrile
  9. 9.Radiation Attenuating Surgical Gloves Market, by Application
    1. 9.1Introduction
    2. 9.2Cardiology
      1. 9.2.1Electrophysiology
      2. 9.2.2Interventional Cardiology
    3. 9.3Interventional Radiology
      1. 9.3.1Neuro Radiology
      2. 9.3.2Vascular Radiology
    4. 9.4Oncology
      1. 9.4.1Brachytherapy
      2. 9.4.2External Beam Therapy
    5. 9.5Orthopedics
    6. 9.6Urology
  10. 10.Radiation Attenuating Surgical Gloves Market, by End User
    1. 10.1Introduction
    2. 10.2Ambulatory Surgical Centers
    3. 10.3Diagnostic Centers
      1. 10.3.1Radiology Centers
      2. 10.3.2Specialty Clinics
    4. 10.4Hospitals
      1. 10.4.1Government Hospitals
      2. 10.4.2Private Hospitals
    5. 10.5Research Institutes
  11. 11.Radiation Attenuating Surgical Gloves Market, by Region
    1. 11.1Introduction
    2. 11.2Asia-Pacific
    3. 11.3North America
    4. 11.4Latin America
    5. 11.5Europe
    6. 11.6Middle East
    7. 11.7Africa
  12. 12.Radiation Attenuating Surgical Gloves Market, by Group
    1. 12.1Introduction
    2. 12.2ASEAN
    3. 12.3GCC
    4. 12.4European Union
    5. 12.5BRICS
    6. 12.6G7
    7. 12.7NATO
  13. 13.Radiation Attenuating Surgical Gloves Market, by Country
    1. 13.1Introduction
    2. 13.2United States
    3. 13.3Canada
    4. 13.4Mexico
    5. 13.5Brazil
    6. 13.6United Kingdom
    7. 13.7Germany
    8. 13.8France
    9. 13.9Russia
    10. 13.10Italy
    11. 13.11Spain
    12. 13.12China
    13. 13.13India
    14. 13.14Japan
    15. 13.15Australia
    16. 13.16South Korea
  14. 14.Competitive Landscape
    1. 14.1Market Share Analysis, 2025
    2. 14.2Market Concentration Analysis, 2025
      1. 14.2.1Concentration Ratio (CR)
      2. 14.2.2Herfindahl Hirschman Index (HHI)
    3. 14.3Recent Developments & Impact Analysis, 2025
    4. 14.4Product Portfolio Analysis, 2025
    5. 14.5Benchmarking Analysis, 2025
  15. 15.Company Profiles
    1. 15.1Ansell Limited
    2. 15.2B. Braun Melsungen AG
    3. 15.3BarrierSafe Solutions International, Inc.
    4. 15.4Bierschneider Medical
    5. 15.5Burkhart Roentgen International
    6. 15.6Cardinal Health, Inc.
    7. 15.7Infab Corporation
    8. 15.8Kirwan Surgical Products LLC
    9. 15.9MAVIG GmbH
    10. 15.10Mercury Medical
    11. 15.11Mölnlycke Health Care AB
    12. 15.12Prima Medical Technologies
    13. 15.13R+P GmbH
    14. 15.14Sempermed USA, Inc.
    15. 15.15TIDI Products, LLC
    16. 15.16Univet S.r.l.
  16. 16.Key Experts

Loading the sample request form…